Clinical Trials in Denver

Showing 2141-2160 of 8,669 trials

A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.

NCT07024407

This is an open-label study of andecaliximab in participants at risk of developing bone where bone should not be, such as in muscle, tendons, and other soft tissues following traumatic spinal cord injury. The goal of this study is to assess the safety of andecaliximab, how much drug is in the body over time (pharmacokinetics/PK), and how it affects the body (pharmacodynamics/PD) in participants who have had a recent traumatic spinal cord injury.

Heterotopic Ossification (HO)

Ashibio Inc10 participantsStarted May 2025

Denver, Colorado, United States

TERMINATEDPhase 2/3< 1 mile

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

NCT05269355

This study will compare the efficacy and safety of unesbulin plus dacarbazine versus placebo plus dacarbazine in participants with unresectable or metastatic, relapsed or refractory LMS who have received at least 1 prior line of systemic therapy.

Leiomyosarcoma

PTC Therapeutics359 participantsStarted May 2022

Duarte, California, United States • Los Angeles, California, United States • Santa Monica, California, United States +51 more locations

A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Find Trials by Condition in Denver

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Multi-Center Adolescent Clavicle Fracture Trial: Operative vs. Non-Operative Treatment

DETECT-RPC Universal EM Screening

Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis

Shared-Decision Making for Hydroxyurea

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

EluPro Antibiotic-Eluting BioEnvelope Registry

Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG®

Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies